Russia Ukraine War | inflation

New Delhi: Domestic equity markets ended the week with mild gains on Friday despite FII selling after hawkish commentary from the Federal Reserve, rising bond yields, escalating geopolitical…

“Sun Pharma is not on my buy list. Companies like Syngene or MNC pharma companies or Dr Lal Path Lab comes to mind immediately, if one wants to get exposure to the healthcare space after…

“We are alpha managers and we do not like hugging the index kind of thought process. It is okay if we underperform for a period but we believe our systems are robust enough to get us in the…

"I still think that one will see about three to four rate hikes in India. But India’s main problem is high fiscal deficit. How are we going to borrow 10.5% worth of GDP equivalent of fiscal…

“The easy money making opportunity is now very clearly behind us and incrementally one has to be very cautious about quality and risk versus reward. The money making opportunities are going…